Consistent with our results, Yao et al. reported that 75 mg/kg/day CH was effective in preventing focal cerebral I/R injury, and they found that SOD activity significantly increased, and MDA content significantly decreased, in the CH treatment group after I/R injury [25]. This evidence concerns the gene SOD1 and cyclic hematopoiesis.